SpectronRx is a CDMO that is FDA and EMA-inspected. The company is licensed to handle multiple Therapeutic and Diagnostic isotope pharmaceutical grades including Pb-212, Lu-177, Ac-225, and I-131, for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF, and Ammonia. Spectron provides labeling and contract manufacturing services related to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64, and Fluorine-18.